XML 23 R13.htm IDEA: XBRL DOCUMENT
v3.25.2

Acquisitions and Divestitures | 12 Months Ended
--- | ---
Mar. 31, 2025
Business Combinations [Abstract] |
Acquisitions and Divestitures | 3. Acquisitions and Divestitures (1) DHC Corporation acquisition On November 11, 2022, in an effort to expand ORIX Group’s network in the healthcare business, the Company executed a share purchase agreement with Mr. Yoshiaki Yoshida, a major shareholder of DHC Corporation (hereinafter, “DHC”), and reached a basic agreement to acquire the shares of DHC. On January 31, 2023, as the date of the business combination, the Company acquired the total number of issued shares of DHC and DHC became a wholly owned subsidiary of the Company. The total cost of the acquisition consideration is ¥300,000 million, which is paid in cash. Transaction costs of ¥3,435 million are included in selling, general and administrative expenses in the Company’s consolidated statements of income for the year ended March 31, 2022 and 2023. The Company allocated the acquisition consideration to DHC’s respective assets acquired and liabilities assumed, and recorded the identified assets and liabilities based on their fair values at the acquisition date by the acquisition method of accounting in accordance with ASC 805 (“Business Combinations”). The Company finalized the purchase price allocation during fiscal 2024. As a result, the following table provides fair value amounts allocated to assets acquired and liabilities assumed from DHC.
|  | Millions of yen |
|  | Preliminary Valuation 2023 |  |  | Adjustments |  |  | Final Valuation 2024 |
Cash and Cash Equivalents |  | ¥ | 101,254 |  |  | ¥ | 0 |  |  | ¥ | 101,254 |
Property under Facility Operations |  |  | 18,790 |  |  |  | (292 | ) |  |  | 18,498 |
Trade Notes, Accounts and Other Receivable |  |  | 11,117 |  |  |  | 0 |  |  |  | 11,117 |
Inventories |  |  | 17,370 |  |  |  | 1,727 |  |  |  | 19,097 |
Office Facilities |  |  | 17,316 |  |  |  | 447 |  |  |  | 17,763 |
Other Assets and other |  |  | 197,840 |  |  |  | 5,390 |  |  |  | 203,230 |
Total Assets |  |  | 363,687 |  |  |  | 7,272 |  |  |  | 370,959 |
Short-Term Debt |  |  | 5,000 |  |  |  | 0 |  |  |  | 5,000 |
Trade Notes, Accounts and Other Payable |  |  | 13,748 |  |  |  | 0 |  |  |  | 13,748 |
Current and Deferred Income Taxes |  |  | 25,472 |  |  |  | 8,095 |  |  |  | 33,567 |
Other Liabilities |  |  | 19,114 |  |  |  | (823 | ) |  |  | 18,291 |
Total Liabilities |  |  | 63,334 |  |  |  | 7,272 |  |  |  | 70,606 |
Noncontrolling interests |  |  | 353 |  |  |  | 0 |  |  |  | 353 |
Net |  | ¥ | 300,000 |  |  | ¥ | 0 |  |  | ¥ | 300,000 |
Goodwill and other intangible assets that were identified in connection with the acquisition are included in other assets in the above table and the Company’s consolidated balance sheet as of March 31, 2024. The amounts of fair value of goodwill and identifiable intangible assets at the time of acquisition were ¥94,324 million and ¥104,910 million, respectively. Goodwill is measured as an excess of consideration transferred over the net assets acquired recognized at fair value. The Company calculated the amount of goodwill based on fair value of assets acquired and liabilities assumed. The goodwill represents the future growth of ORIX Group from new revenue streams arising from the consolidation of DHC and synergies with the existing Company’s assets and businesses. The goodwill is not deductible for income tax purposes. The goodwill and other intangible assets recorded in connection with this acquisition are included in PE Investment and Concession segment. Other intangible assets recognized in this acquisition consist of the following:
|  | Millions of yen |  |  | Years |
|  | Acquired intangibles recorded at fair value |  |  | Weighted-average amortization period |
Intangible assets that have indefinite useful lives: |  |  |  |  |  |  |  |
Trademarks and trade names |  | ¥ | 77,721 |  |  |  | — |
Subtotal |  |  | 77,721 |  |  |  |  |
Intangibles subject to amortization: |  |  |  |  |  |  |  |
License |  |  | 15,976 |  |  |  | 15 |
Customer relationships |  |  | 11,213 |  |  |  | 16 |
Subtotal |  |  | 27,189 |  |  |  |  |
Total |  | ¥ | 104,910 |  |  |  |  |
The following unaudited supplemental pro forma financial information presents the combined results of operations of the Company and its subsidiaries as though the acquisition had occurred as of April 1, 2021, the beginning of the fiscal year ended March 31, 2022:
|  | Millions of yen |
|  | March 31, 2023 |
Total revenues |  | ¥ | 2,754,190 |
Net Income |  |  | 310,937 |
There are no total revenues and net income of DHC after acquisition included in the Company’s consolidated statement of income for the fiscal year ended March 31, 2023. The unaudited supplemental pro forma financial information is based on estimates and assumptions, that the Company believes are reasonable and should not be taken as indicative of what the Company’s consolidated financial results would have been had the acquisition been completed on that date. (2) Other Acquisitions During fiscal 2023, the Company and its subsidiaries acquired entities, other than DHC, for a total cost of the acquisition consideration of ¥60,876 million, which was paid mainly in cash. Goodwill initially recognized in these transactions amounted to ¥17,644 million and the goodwill is not deductible for income tax purposes. The amount of acquired intangible assets other than goodwill recognized in these transactions was ¥31,087 million. The acquisitions were mainly included in PE Investment and Concession segment. During fiscal 2024, the Company and its subsidiaries acquired entities for a total cost of the acquisition consideration of ¥11,894 million, which was paid mainly in cash. Goodwill initially recognized in these transactions amounted to ¥4,241 million and the goodwill is not deductible for income tax purposes. The amount of acquired intangible assets other than goodwill recognized in these transactions was ¥7,049 million. The acquisitions were mainly included in PE Investment and Concession segment. During fiscal 2025, the Company and its subsidiaries acquired entities for a total cost of the acquisition consideration of ¥33,041 million, which was paid mainly in cash. Goodwill initially recognized in these transactions amounted to ¥9,081 million and the goodwill is not deductible for income tax purposes. The amount of acquired intangible assets other than goodwill recognized in these transactions was ¥21,684 million. The Company reflected certain preliminary estimates with respect to the fair value of certain components of the underlying net assets of these entities in determining amounts of the goodwill. The amount of the goodwill and intangible assets could possibly be adjusted because for certain of these acquisitions, the purchase price allocations have not been completed yet with respect to the final valuation of acquired intangible assets among others. The acquisitions were mainly included in PE Investment and Concession segment. As a result of the assessment of the purchase price allocation, the Company recognized a bargain purchase gain of ¥1,174 million during fiscal 2023 associated with four of its acquisitions during fiscal 2023, due to the fair value of the net assets, which is the difference between the assets acquired and the liabilities assumed, exceeding the fair value of consideration transferred. The bargain purchase gain was mainly included in Environment and Energy segment. The Company did not recognize any bargain purchase gain during fiscal 2024. As a result of the assessment of the purchase price allocation, the Company recognized a bargain purchase gain of ¥3,750 million during fiscal 2025 associated with one of its acquisitions during fiscal 2025, due to the fair value of the net assets, which is the difference between the assets acquired and the liabilities assumed, exceeding the fair value of consideration transferred. The bargain purchase gain was included in Asia and Australia segment. The segment in which goodwill is allocated is disclosed in Note 13 “Goodwill and Other Intangible Assets.” (3) Divestitures Gains on sales of subsidiaries and equity method investments and liquidation losses, net for fiscal 2023, 2024 and 2025 amounted to ¥33,000 million, ¥72,488 million and ¥87,705 million, respectively. Gains (losses) on sales of subsidiaries and equity method investments and liquidation losses, net for fiscal 2023 mainly consisted of ¥137 million in Real Estate segment, ¥2,367 million in PE Investment and Concession segment, ¥16,698 million in Environment and Energy segment, ¥(1,076) million in Aircraft and Ships segment, ¥10,201 million in ORIX USA segment and ¥4,676 million in Asia and Australia segment. Gains (losses) on sales of subsidiaries and equity method investments and liquidation losses, net for fiscal 2024 mainly consisted of ¥19,822 million in PE Investment and Concession segment, ¥(5,557) million in Environment and Energy segment, ¥57,470 million in Banking and Credit segment, ¥(1,978) million in ORIX USA segment and ¥2,502 million in ORIX Europe segment. Gains (losses) on sales of subsidiaries and equity method investments and liquidation losses, net for fiscal 2025 consisted of ¥7,294 million in Corporate Financial Services and Maintenance Leasing segment, ¥350 million in Real Estate segment, ¥44,503 million in PE Investment and Concession segment, ¥6,365 million in Environment and Energy segment, ¥478 million in Aircraft and Ships segment, ¥29,224 million in ORIX USA segment, ¥(624) million in ORIX Europe segment and ¥115 million in Asia and Australia segment. During fiscal 2024, the Company sold 66% of the common shares of a consolidated subsidiary, ORIX Credit Corporation (hereinafter, “ORIX Credit”, which changed its name to DOCOMO Finance, Inc on April 1, 2025) to a third-party. The Company retains a 34% interest in ORIX Credit, which became an equity method investment from fiscal 2024. The sale of the controlling interest resulted in a gain ¥37,930 million, and the remeasurement of the retained interest to its fair value resulted in a gain of ¥19,540 million, both of which were included in earnings as gains on sales of subsidiaries and equity method investment and liquidation losses, net during fiscal 2024. The fair value of the retained interest was remeasured using the stock value based on the sale proceed.

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 805 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/805/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/205-20/tableOfContent + Details
Name: | us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration